Key Considerations for the Management of RSV in Adult Patients : Episode 10

Opinion

Video

July 22, 2024

Addressing Vaccine Fatigue

Author(s):

Ryan Haumschild, PharmD, MS, MBA,Wanda Filer, MD, MBA

Mary Bridgeman, PharmD, BCPS, BCGP, discusses how providers and healthcare workers can address vaccine fatigue in patients eligible for the RSV vaccine.

EP: 1.Overview of RSV Patient Populations

EP: 2.Complications Associated with RSV Infections

EP: 3.The Economic Burden and Main Drivers of Healthcare Resource Utilization in RSV

EP: 4.RSV: Risk Factors and How It’s Spread

EP: 5.Diagnostic Practices for RSV

EP: 6.Increasing Awareness of RSV Vaccines in At-Risk Patients

EP: 7.Shared Decision-Making Practices in RSV

EP: 8.Financial and Clinical Benefits of RSV Immunization

EP: 9.The Potential Benefits of RSV Vaccine Approval for Adults Aged 50-59

EP: 10.Addressing Vaccine Fatigue

EP: 11.Identifying Patients Eligible for RSV Vaccine

EP: 12.Current and Potential Obstacles Related to Administering RSV Vaccines

EP: 13.Improving Insurance Coverage for RSV Vaccines

EP: 14.Improving RSV Vaccination Rates and Addressing Misinformation

EP: 15.Key Takeaways on RSV Vaccination

Video content above is prompted by the following question:

How can providers and healthcare workers address vaccine fatigue in eligible patients?

Related Videos

Related Content

RSV, COVID, Flu vaccines. | Image credit: angellodeco - stock.adobe.com

February 19th 2025

Nirsevimab, RSVpreF Saw High Uptake With No Preterm Risk for RSVpreF

High vaccine uptake shows promise for the prevention of respiratory syncytial virus (RSV) in infants.

Nursing home care | Image credit: Kzenon - stock.adobe.com

November 24th 2024

Low RSV Vaccination Rates in Nursing Homes Highlight Urgent Need for Uptake

Significant gaps in vaccination coverage among nursing home residents leaves vulnerable populations at risk for severe complications, report finds.

Air purifier | Image credit: Prathankarnpap - stock.adobe.com

November 22nd 2024

In-Room Air Purifiers Could Impact RSV Incidence Among Older Adults

Kennedy Ferruggia

Use of in-room air purifiers with HEPA-14 filters did not result in a significant reduction of acute respiratory infections.

RSV risk survey | Image credit: Richelle - stock.adobe.com

November 20th 2024

Community Pharmacies Hold Key Role in Protecting Older Adults From RSV

New research reveals gaps in respiratory syncytial virus (RSV) knowledge among older adults and emphasizes the impact community pharmacies can have at improving education and vaccine uptake.

Blood sample tube for RSV test. | Image credit: JUN LI - stock.adobe.com

November 15th 2024

RSV Vaccine Proven Effective in Reducing RSV-Related Hospitalizations

Kennedy Ferruggia

Respiratory syncytial virus (RSV) vaccination is approximately 77% to 81% effective against hospital and emergency department encounters among older adults, study finds.

RSV, COVID, Flu vaccines. | Image credit: angellodeco - stock.adobe.com

November 14th 2024

Impact of RSV on Hospitalizations in US Adults Prior to Vaccine Introduction

Respiratory syncytial virus (RSV) caused significant hospitalizations and severe outcomes in adults, especially those aged 75 years and older.

Related Content

RSV, COVID, Flu vaccines. | Image credit: angellodeco - stock.adobe.com

February 19th 2025

Nirsevimab, RSVpreF Saw High Uptake With No Preterm Risk for RSVpreF

High vaccine uptake shows promise for the prevention of respiratory syncytial virus (RSV) in infants.

Nursing home care | Image credit: Kzenon - stock.adobe.com

November 24th 2024

Low RSV Vaccination Rates in Nursing Homes Highlight Urgent Need for Uptake

Significant gaps in vaccination coverage among nursing home residents leaves vulnerable populations at risk for severe complications, report finds.

Air purifier | Image credit: Prathankarnpap - stock.adobe.com

November 22nd 2024

In-Room Air Purifiers Could Impact RSV Incidence Among Older Adults

Kennedy Ferruggia

Use of in-room air purifiers with HEPA-14 filters did not result in a significant reduction of acute respiratory infections.

RSV risk survey | Image credit: Richelle - stock.adobe.com

November 20th 2024

Community Pharmacies Hold Key Role in Protecting Older Adults From RSV

New research reveals gaps in respiratory syncytial virus (RSV) knowledge among older adults and emphasizes the impact community pharmacies can have at improving education and vaccine uptake.

Blood sample tube for RSV test. | Image credit: JUN LI - stock.adobe.com

November 15th 2024

RSV Vaccine Proven Effective in Reducing RSV-Related Hospitalizations

Kennedy Ferruggia

Respiratory syncytial virus (RSV) vaccination is approximately 77% to 81% effective against hospital and emergency department encounters among older adults, study finds.

RSV, COVID, Flu vaccines. | Image credit: angellodeco - stock.adobe.com

November 14th 2024

Impact of RSV on Hospitalizations in US Adults Prior to Vaccine Introduction

Respiratory syncytial virus (RSV) caused significant hospitalizations and severe outcomes in adults, especially those aged 75 years and older.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions